Antimicrobial Susceptibility StudyIn vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci
References (19)
- et al.
Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital
Diagn Microbiol Infect Dis
(2010) - et al.
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
Drug Resist Updat
(2014) - et al.
Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances
Antimicrob Agents Chemother
(2008) Performance standards for antimicrobial susceptibility testing twenty-fourth informational supplement M100-S24
(2014)- et al.
Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio
Antimicrob Agents Chemother
(2011) - et al.
The emerging problem of linezolid-resistant Staphylococcus
J Antimicrob Chemother
(2013) - et al.
Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium
N Engl J Med
(2002) - et al.
A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis
J Antimicrob Chemother
(2009) - et al.
Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
J Antimicrob Chemother
(2009)
There are more references available in the full text version of this article.
Cited by (0)
© 2016 Elsevier Inc. All rights reserved.